United States: Celltrion Expands Access To YUFLYMA (Adalimumab-Aaty) - Goodwin Procter LLP

On October 5, Celltrion Healthcare Co. announced that it has signed a contract with Ventegra, a major U.S. Medical Benefits Manager (MBM) "who administers pharmacy benefits through its Pharmacy Services...